clinical trial · NCT06365840
A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor
TMB-HHistologically or Cytologically Proven Metastatic or Locally Advanced Solid TumorsIMC-001
brief summary
The goal of this clinical trial is to determine the efficacy of IMC-001 in metastatic or locally advanced TMB-H solid tumor patients.
started
Jan 13, 2025
primary completion
Jun 30, 2027
completion
Aug 1, 2029
last updated
Apr 17, 2026
official title
PHASE 2 STUDY OF IMC-001 IN PATIENTS WITH METASTATIC OR LOCALLY ADVANCED TMB-H SOLID TUMOR
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol